Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IRRAS Announces Expansion of IRRAflow Launch to Latin America

· Finalization of agreement with distribution partner in Argentina allows access into initial Latin American markets · Anade SA is a well-established partner with deep existing relationships in neurosurgical spaceStockholm, December 10, 2020 – IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced an exclusive distribution agreement with Anade SA, a well-established distributor of leading neurosurgical medical devices and technologies through Latin America. “We are pleased to partner with

Realising opportunities for future growth and financial update: Sobi Capital Markets Day 2020

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI ) is hosting a virtual Capital Markets Day today. Presentations from senior management will showcase Sobi’s strategy for growth in the core areas of Immunology and Haematology, strengthening its pipeline, extending its geographical footprint and expanding growth opportunities. New peak sales expectations for key products as well as revenue ambition for 2025 are communicated.   “Sobi has been through a significant transformation in the past few years and we are now well positioned for the next phase,” says Guido

Realheart's CEO invited to speak at EUMS

The European Mechanical Circulatory Support Summit is one of the world's largest medical congresses in heart pumps. This year, Realheart's CEO Azad Najar was invited to talk about the company's artificial heart and the research that is being conducted.The European Mechanical Circulatory Support Summit brings together the world elite in heart pump surgery, both industry representatives and researchers. This fifteenth congress took place digitally during five days from 30 November to 4 December. Azad Najar, CEO of Realheart, was contacted by the Congress' Scientific Committee with an

Systemair AB Interim Report Q2 2020/21

Press Release, December 10, 2020 Second quarter, August – October 2020 · Net sales decreased 11.1 percent, to SEK 2,207 million (2,483). · Organic growth was -3.8 percent (+6.0). · Operating profit (EBIT) amounted to SEK 214 million (284), including a goodwill impairment charge of SEK -11 million. · The operating margin was 9.7 percent (11.4). · Profit after tax amounted to SEK 141 million (194). · Earnings per share totalled SEK 2.70 (3.72). · Cash flow from operating activities amounted to SEK 285 million (297). Roland Kasper, President and CEO, comments:“

Veidekke ASA: Construction job at the proton centre in Bergen

Veidekke has been commissioned by Helse Bergen HF to carry out the groundworks for the new proton centre at Haukeland University Hospital in Bergen. The contract is a design and build contract with a value of NOK 116 million, excluding VAT.Veidekke will prepare the site for the new building, which entails demolishing an existing parking facility, securing the rock face behind the building and blasting a 650 metres tunnel and 60 metres lift shaft to the central building to link the proton centre to the rest of the hospital. The new proton centre will be located in Haukelandsbakken, just

SOTKAMO SILVER AB: PUBLICATION OF THE REVISED STRATEGY

Press release: Stockholm, December 10, 2020 07:45 CETSotkamo Silver AB will announce its revised strategy for 2021-2025 today, December 10, 2020, at 10:00 am Finnish time in a virtual event. The Group's revised strategy, presented in the event, is based on the responsibility and support to the local development. The event will be held in Finnish and the material presented will be in English. The presentation will be available at approximately 09:45 Finnish time on the company's website at: https://www.silver.fi/en/investors/presentations Stockholm, December 10, 2020 Sotkamo

STOREBRAND ASA: Capital Markets Day today at 14:00 CET

STRATEGY 2021-2023: LEADING THE WAY IN SUSTAINABLE VALUE CREATIONStorebrand is hosting a virtual Capital Markets Day today at 14:00 CET, outlining the Group strategic plan for 2021-2023 'Leading the Way in Sustainable Value Creation'. The presentation includes dedicated sessions on occupational pensions, asset management, retail and cash and capital.   – Storebrand has followed an active and consistent strategy with a proven track record of shifting the business mix towards capital light savings and insurance products, replacing legacy guaranteed business. The Storebrand of the future

Social media provides small and medium-sized firms (SMEs) with tools to mitigate internationalisation-related threats

For SMEs seeking to enter the international markets, social media is a tool for overcoming liabilities connected to their smallness, newness and foreignness, a new study from the University of Eastern Finland shows. According to the study, SMEs use social media to become embedded within various strategic and emerging international networks they deem important for their operations. “Companies seeking to go global are often unsure about how to best use social media and international networks to tackle any obstacles standing between them and the international markets. Our findings can help

Investing for a Sustainable Future: Swedish Space Corporation (SSC) invests in exciting new UK/Swedish start-up “GlobalTrust”

SSC is pleased to announce investment in a new start-up data analytics business with offices in the UK and Sweden to address some of the most crucial environmental and social issues of the time. GlobalTrust will focus on supporting public policy and corporate social responsibility imperatives that are aligned with societies’ expectations and working towards a better and more sustainable planet. This initiative is being led by SSC and is supported by the UK’s Satellite Applications Catapult – a government established not-for-profit company with its core mandate focused on promoting and

Targovax to present at DNB’s 11[th] Annual Nordic Healthcare Conference

Oslo, 10 December 2020 – Targovax ASA, announces that Øystein Soug, CEO of Targovax, will present the company at DNB’s 11[th] Annual Nordic Healthcare Conference, Tuesday 15 December.DNB’s 11[th] Annual Nordic Healthcare ConferenceDate: 15 December 2020Presenter: Øystein Soug, CEOPresentation time: 12:30 CETThe presentation will be available to download at www.targovax.com  after the event.

Axactor SE - Key information relating to the contemplated subsequent offering in Axactor SE

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Date of the announcement of the subsequent offering: 9 December 2020 Last day including right: 9 December 2020 Ex-date: 10 December 2020 Record date: 11 December 2020 Date of EGM approval: 5 January 2020 Number of new shares: Up to 26,750,000

Essity announces proposal to increase ownership in Asaleo Care Limited

Essity Aktiebolag (publ) (“Essity”) today announced that Essity has made a non-binding indicative proposal to the Board of the hygiene company Asaleo Care Limited (“Asaleo”) for the acquisition of additional shares in Asaleo for a consideration of AUD 1.26 per share. Asaleo is listed on the Australian Securities Exchange (ASX). Essity is the largest shareholder of Asaleo, currently holding 36.2% of the shares. Asaleo’s current market capitalization on ASX is AUD 549m, based on the closing market price 1.01 AUD on 9 December 2020.There can be no certainty that any agreement will be reached,

Axactor SE - Private placement of new shares successfully placed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL    Oslo, Norway, 9 December 2020  Reference is made to the stock exchange announcement by Axactor SE (OSE: AXA) ("Axactor" or the "Company") on 9 December 2020 regarding the contemplated private placement of 40 million new shares (the "Offer Shares"), representing 21.

Full data set of Oncopeptides phase 2 HORIZON study in multiple myeloma published in the Journal of Clinical Oncology

STOCKHOLM — December 9, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the pivotal phase 2 HORIZON study evaluating intravenous melflufen (INN melphalan flufenamide) in combination with dexamethasone in relapsed refractory multiple myeloma, has been published in the peer-reviewed Journal of Clinical Oncology.The phase 2 HORIZON data are the basis for the ongoing priority review of the New Drug Application to the US Food and Drug

REPSOL AND TACTOTEK WILL DEVELOP SMART SURFACES WITH POLYOLEFINS

Repsol and TactoTek seek to expand the use of polyolefins in high-performance parts, such as smart surfaces, which have only been made using other plastic materials.MADRID, SPAIN December 9th 2020 - Polyolefins are the most widely used polymers in the automotive sector due to their exceptional versatility, superior physical and mechanical characteristics, and lightweight, which reduces fuel consumption and emissions. At the end of 2019, Repsol made an equity investment in the Finnish startup TactoTek, through its investment fund Repsol Corporate Venturing 

Inzile’s production volume for 2020 is limited by component shortages

Difficulties with component supply continue to slow down Inzile's production. The current pandemic initially caused delays in deliveries of necessary components, but quality problems with a subcontractor have also recently been recorded. We have taken measures to secure the component supply and our hope is that it will function more normally in the future. The production line works well and Inzile predicts that a total of 50 vehicles will be completed this year, compared to what was communicated on September 24, 120 vehicles. Assuming normalized deliveries of components, Inzile expects to

Notice of Extraordinary General Meeting in InDex Pharmaceuticals Holding AB

December 9, 2020 – Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820, are hereby summoned to an Extraordinary General Meeting on Tuesday 12 January, 2021 at 10.00 p.m. (CET) through advance voting. Attendance at the meeting is only possible via postal ballot.Information in relation to the corona virus (COVID-19)In view of the recent developments of the spread of the corona virus (COVID-19), the board of directors has, in accordance with section 20 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other

Calmark certified according to ISO 13485:2016

Calmark Sweden AB has carried out a certification of its quality management system in accordance with ISO 13485:2016. Review and certification were conducted by RISE Research Institutes of Sweden AB.Calmark Sweden AB has today received its certificate according to ISO 13485:2016 (Medical devices — Quality management systems — Requirements for regulatory purposes). The certificate was awarded by RISE Research Institutes of Sweden AB (RISE AB), confirming that Calmark's quality management system meets the requirements for development, production, sales and distribution of in vitro diagnostic

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.12.2020

United Bankers Corporation NOTIFICATION 09.12.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.12.2020 Date 09.12.2020Exchange transaction BuyShare class UNIAVAmount 578Average price/share 9.5293 EURHighest price/share 9.5500 EURLowest price/share 9.5000 EURTotal price 5,507.94 EUR The shares held by United Bankers Corporation on 09.12.2020: UNIAV 33,119   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

MUSTI GROUP PLC: Share Repurchase 9.12.2020

Musti Group Stock Exchange Release 9.12.2020 MUSTI GROUP PLC: Share Repurchase 9.12.2020 In the NASDAQ OMX Helsinki Trade date           9.12.2020Bourse trade         BuyShare                  MUSTIAmount             10 000 SharesAverage price/ share    23,1143 EURTotal cost            231 143,00 EUR Company now holds a total of 61 000 sharesincluding the shares repurchased on 9.12.2020 On behalf of Musti Group Nordea Bank Finland Plc Janne Sarvikivi

Stena Line connects to shore power in Kiel

Today´s inauguration of the new shore power facility in Kiel means that Stena Line now have the possibility to connect 14 vessels at seven terminals with on-shore electricity during port stay. The new connection in Kiel will reduce the CO\2 \emissions from the two vessels Stena Scandinavica and Stena Germanica with 2,700 tonnes per year. In total Stena Line reduce its CO\2 \emissions with shore power with 13,000 tonnes per year.The new shore power facility in Kiel provides 100% green electricity, thus also avoiding NO\X\-, SO\X\- and particle emissions during the port stay of Stena

Primary insider trade

Erik Ranberg, CIO in Gjensidige Forsikring ASA, has today bought 500 shares in Gjensidige at NOK 185.50 per share. Ranberg and closely related parties hold 15 162 shares in Gjensidige Forsikring ASA after the transaction. This information is subject to disclosure under the Norwegian Securities Act section §5-12. Contact persons, Gjensidige Forsikring ASA: Head of Investor Relations Mitra Hagen Negård, Tel: +47 957 93 631 Head of Communication Øystein Thoresen, Tel: +47 952 33 382

Correction: Disclosure of changes in holdings: R-Venture sold 15,002 shares in 24SevenOffice Scandinavia AB

R-Venture AS has today sold 15,002 shares in 24SevenOffice Scandinavia AB at a price of SEK 39.5141 per share. The company now controls 30,117,217 shares together with its 100% owned subsidiary BMU AS, equal to one share less than 50% of the total shares. The reason for the sale is that the company no longer wants to be a parent company with the obligations it entails, as for instance working out inter-company group accounts. At the same time, R-Venture clarifies that they want to retain their current ownership and have no current plans for further divestments.  Corrected due to

There are no items matching the current filter
There are no more items matching the current filter
Back to top